BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31661160)

  • 1. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
    Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
    Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
    Khan M; Siddiqi R; Naqvi K
    Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
    Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
    Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
    Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
    Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
    Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
    Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
    Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
    Porwit A; Béné MC
    Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.
    Munker R; Brazauskas R; Wang HL; de Lima M; Khoury HJ; Gale RP; Maziarz RT; Sandmaier BM; Weisdorf D; Saber W;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1024-1029. PubMed ID: 26903380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
    Cernan M; Szotkowski T; Pikalova Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):234-241. PubMed ID: 28422191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
    Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
    Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population-based study.
    Zając-Spychała O; Irga-Jaworska N; Drożyńska E; Muszyńska-Rosłan K; Krawczuk-Rybak M; Zawitkowska J; Kowalczyk J; Ćwiklińska M; Balwierz W; Mizia-Malarz A; Badowska W; Kamieńska E; Urasiński T; Kaczorowska A; Kazanowska B; Chybicka A; Wysocki M; Sędek Ł; Szczepański T; Woszczyk M; Matysiak M; Młynarski W; Karolczyk G; Chaber R; Wachowiak J
    Eur J Haematol; 2020 Jul; 105(1):85-93. PubMed ID: 32223036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
    Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis.
    Maruffi M; Sposto R; Oberley MJ; Kysh L; Orgel E
    Leukemia; 2018 Jul; 32(7):1515-1528. PubMed ID: 29550836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
    Hrusak O; de Haas V; Stancikova J; Vakrmanova B; Janotova I; Mejstrikova E; Capek V; Trka J; Zaliova M; Luks A; Bleckmann K; Möricke A; Irving J; Konatkowska B; Alexander TB; Inaba H; Schmiegelow K; Stokley S; Zemanova Z; Moorman AV; Rossi JG; Felice MS; Dalla-Pozza L; Morales J; Dworzak M; Buldini B; Basso G; Campbell M; Cabrera ME; Marinov N; Elitzur S; Izraeli S; Luria D; Feuerstein T; Kolenova A; Svec P; Kreminska O; Rabin KR; Polychronopoulou S; da Costa E; Marquart HV; Kattamis A; Ratei R; Reinhardt D; Choi JK; Schrappe M; Stary J
    Blood; 2018 Jul; 132(3):264-276. PubMed ID: 29720486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study.
    Oberley MJ; Raikar SS; Wertheim GB; Malvar J; Sposto R; Rabin KR; Punia JN; Seif AE; Cahen VC; Schore RJ; Luca DC; Guinipero T; Woods WG; O'Gorman MRG; Orgel E
    Leukemia; 2020 Jul; 34(7):1741-1750. PubMed ID: 32060402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone.
    Tian H; Xu Y; Liu L; Yan L; Jin Z; Tang X; Han Y; Fu Z; Qiu H; Sun A; Wu D
    Leuk Res; 2016 Jun; 45():40-6. PubMed ID: 27088964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India.
    Rai V; Brahmbhatt B; Saha A; Thayakaran IP
    Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with mixed phenotype acute leukemia in Morocco.
    Bachir F; Zerrouk J; Howard SC; Graoui O; Lahjouji A; Hessissen L; Bennani S; Quessar A; El Aouad R
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e392-7. PubMed ID: 23619119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.